Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
medline: 19 9 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Apathy and depression are two early behavioral symptoms in Alzheimer's disease (AD) and related disorders that often occur prior to the onset of cognitive decline and memory disturbances. Both have been associated with an increased risk of conversion to dementia, with a distinct neuropathology. The assessment of the trajectories of apathy and depression and their independent impact on dementia conversion. Apathy and Depression were measured using the Neuropsychiatric Inventory for caregiver (NPI) and clinician (NPI-C), among the nondemented individuals reporting subjective cognitive decline (SCD) at baseline. They were followed up over a 60-month period. Some converted to dementia, according to the methodology carried out by the French Memento Cohort. Among individuals with SCD (n = 2,323), the levels of apathy and depression were low and did not evolve significantly over the 60-month period, despite a trend in apathy increasing as of month 24. Regarding SCD individuals who converted to dementia within the 60-month period (n = 27), the prevalence of depression remained globally steady, while the levels of apathy increased over time. Apathy and depression have different trajectories among individuals with SCD and apathy alone is more likely-compared to depression-to be associated with conversion to dementia.

Sections du résumé

BACKGROUND
Apathy and depression are two early behavioral symptoms in Alzheimer's disease (AD) and related disorders that often occur prior to the onset of cognitive decline and memory disturbances. Both have been associated with an increased risk of conversion to dementia, with a distinct neuropathology.
OBJECTIVE
The assessment of the trajectories of apathy and depression and their independent impact on dementia conversion.
METHODS
Apathy and Depression were measured using the Neuropsychiatric Inventory for caregiver (NPI) and clinician (NPI-C), among the nondemented individuals reporting subjective cognitive decline (SCD) at baseline. They were followed up over a 60-month period. Some converted to dementia, according to the methodology carried out by the French Memento Cohort.
RESULTS
Among individuals with SCD (n = 2,323), the levels of apathy and depression were low and did not evolve significantly over the 60-month period, despite a trend in apathy increasing as of month 24. Regarding SCD individuals who converted to dementia within the 60-month period (n = 27), the prevalence of depression remained globally steady, while the levels of apathy increased over time.
CONCLUSION
Apathy and depression have different trajectories among individuals with SCD and apathy alone is more likely-compared to depression-to be associated with conversion to dementia.

Identifiants

pubmed: 37545236
pii: JAD230162
doi: 10.3233/JAD-230162
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-426

Auteurs

Anamaria Bogdan (A)

Cote d'Azur University, Nice University Hospital, Department of Old Age Psychiatry, Nice, France.

Roxane Fabre (R)

Nice University Hospital, Department of Public Health, Nice, France.

Thomas Desmidt (T)

Tours University Hospital, Tours, France.

Jérôme Golebiowski (J)

Côte D'Azur University, Chemistry Institute of Nice, France.

Jérémie Topin (J)

Côte D'Azur University, Chemistry Institute of Nice, France.

Ingrid Bethus (I)

Côte d'Azur University, IPMC (Institut de Pharmacologie Moléculaire et cellulaire), Sophia Antipolis, France.

Olivier Hanon (O)

Université Paris Cité - EA4468 APHP-Hôpitaux Universitaires Paris Centre - Service de Gériatrie- hôpital Broca, Paris, France.

Claire Boutoleau-Bretonniere (C)

Memory Clinic (CMRR), Nantes University Hospital, Nantes, France.

Nathalie Wagemann (N)

Memory Clinic (CMRR), Nantes University Hospital, Nantes, France.

Cédric Annweiler (C)

Angers University Hospital, Angers, France.

Pierre-Jean Ousset (PJ)

Toulouse Clinical Research Center, Toulouse University Hospital, Toulouse, France.

Olivier Godefroy (O)

Department of Neurology, Amiens University Hospital, Amiens, France.

Isabelle Rouch (I)

Memory Clinic (CMRR) Saint Etienne, INSERM U1219, Bordeaux, France.

Marc Paccalin (M)

Department of Geriatry, Memory Clinic (CMRR), CIC U1402, Poitiers University Hospital, Poitiers, France.

Maryana Sukhorukova (M)

Auhof St, 1130 Wien, Austria.

Audrey Gabelle (A)

Memory Clinic (CMRR), Montpellier University Hospital, Montpellier, France.

Gabriel Robert (G)

Centre Hospitalier Universitaire de Rennes.

Renaud David (R)

Cote d'Azur University, Nice University Hospital, Department of Old Age Psychiatry, Nice, France.
NICE BRAIN non-profitorganization for research on brain, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH